Literature DB >> 19064020

Change in high-density lipoprotein cholesterol and incident coronary heart disease in apparently healthy male physicians.

Catherine Rahilly-Tierney1, Thomas S Bowman, Luc Djoussé, Howard D Sesso, J Michael Gaziano.   

Abstract

The association between change in high-density lipoprotein (HDL) cholesterol and risk of subsequent coronary heart disease (CHD) is unclear. Change in HDL cholesterol was calculated in a prospective cohort of 4,501 male physicians enrolled in the Physician's Health Study (PHS) I who had HDL cholesterol measured in 1982 and again approximately 14 years later. Subjects were divided into categories of those with a decrease (>or=-2.5 mg/dl), no change (change -2.5 to 2.5 mg/dl), a small increase of 2.5 to 12.5 mg/dl, or a large increase of >or=12.5 mg/dl. Cox proportional hazards was used to examine the association between change in HDL cholesterol and incident CHD (confirmed acute myocardial infarction or cardiac death). Hazard ratios (HRs) were adjusted for age, initial HDL cholesterol, diabetes mellitus, hypertension, non-HDL cholesterol, and history of cholesterol medication. Compared with subjects with a decrease in HDL cholesterol, multivariable-adjusted HRs for CHD were 0.66 (95% confidence interval [CI] 0.40 to 1.09) in subjects with no change, 0.56 (95% CI 0.35 to 0.89) for subjects with an increase of 2.5 to 12.5 mg/dl, and 0.43 (95% CI 0.23 to 0.83) for subjects with an HDL cholesterol increase >or=12.5 mg/dl. In conclusion, our findings were consistent with an inverse graded relation between 14-year increase in HDL cholesterol and risk of subsequent CHD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19064020      PMCID: PMC2670559          DOI: 10.1016/j.amjcard.2008.07.055

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  28 in total

1.  Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy.

Authors:  Christopher P Cannon; Benjamin A Steinberg; Sabina A Murphy; Jessica L Mega; Eugene Braunwald
Journal:  J Am Coll Cardiol       Date:  2006-07-12       Impact factor: 24.094

2.  Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.

Authors:  C Baigent; A Keech; P M Kearney; L Blackwell; G Buck; C Pollicino; A Kirby; T Sourjina; R Peto; R Collins; R Simes
Journal:  Lancet       Date:  2005-09-27       Impact factor: 79.321

3.  Association of high-density-lipoprotein cholesterol with mortality and other risk factors for major chronic noncommunicable diseases in samples of US and Russian men.

Authors:  N V Perova; R G Oganov; D H Williams; S H Irving; J R Abernathy; A D Deev; D B Shestov; G S Zhukovsky; C E Davis; H A Tyroler
Journal:  Ann Epidemiol       Date:  1995-05       Impact factor: 3.797

4.  Total, LDL, and HDL cholesterol decrease with age in older men and women. The Rancho Bernardo Study 1984-1994.

Authors:  A Ferrara; E Barrett-Connor; J Shan
Journal:  Circulation       Date:  1997-07-01       Impact factor: 29.690

5.  Determinants of change in total cholesterol and HDL-C with age: the Framingham Study.

Authors:  P W Wilson; K M Anderson; T Harris; W B Kannel; W P Castelli
Journal:  J Gerontol       Date:  1994-11

6.  Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis.

Authors:  A M Dattilo; P M Kris-Etherton
Journal:  Am J Clin Nutr       Date:  1992-08       Impact factor: 7.045

7.  High-density lipoprotein cholesterol and coronary, cardiovascular and all cause mortality among middle-aged Norwegian men and women.

Authors:  I Stensvold; P Urdal; H Thürmer; A Tverdal; P G Lund-Larsen; O P Foss
Journal:  Eur Heart J       Date:  1992-09       Impact factor: 29.983

8.  Relation between on-treatment increments in serum high-density lipoprotein cholesterol levels and cardiac mortality in patients with coronary heart disease (from the Bezafibrate Infarction Prevention trial).

Authors:  Ilan Goldenberg; Uri Goldbourt; Valentina Boyko; Solomon Behar; Henrietta Reicher-Reiss
Journal:  Am J Cardiol       Date:  2005-12-22       Impact factor: 2.778

9.  Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease.

Authors:  C H Hennekens; J E Buring; J E Manson; M Stampfer; B Rosner; N R Cook; C Belanger; F LaMotte; J M Gaziano; P M Ridker; W Willett; R Peto
Journal:  N Engl J Med       Date:  1996-05-02       Impact factor: 91.245

10.  Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction.

Authors:  J M Gaziano; J E Buring; J L Breslow; S Z Goldhaber; B Rosner; M VanDenburgh; W Willett; C H Hennekens
Journal:  N Engl J Med       Date:  1993-12-16       Impact factor: 91.245

View more
  5 in total

1.  Lifestyle change and high-density lipoprotein change: the US Department of Veterans Affairs Normative Aging Study.

Authors:  Catherine Rahilly-Tierney; Pantel Vokonas; J Michael Gaziano; Avron Spiro
Journal:  Clin Cardiol       Date:  2012-03-08       Impact factor: 2.882

2.  Efficacy and safety of ezetimibe for Japanese patients with dyslipidaemia: The ESSENTIAL Study.

Authors:  Yasunori Sawayama; Shinji Maeda; Hachiro Ohnishi; Shin Hayashi; Jun Hayashi
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

3.  Influence of mitochondrial DNA 5178 C/A polymorphism on serum cholesterol changes: a short-term follow-up in middle-aged Japanese men.

Authors:  Rie Honmyo; Akatsuki Kokaze; Kanae Karita; Masao Yoshida; Mamoru Ishikawa; Hideki Ohno
Journal:  Environ Health Prev Med       Date:  2012-02-19       Impact factor: 3.674

4.  Progression of conventional cardiovascular risk factors and vascular disease risk in individuals: insights from the PROG-IMT consortium.

Authors:  Martin Bahls; Matthias W Lorenz; Marcus Dörr; Lu Gao; Kazuo Kitagawa; Tomi-Pekka Tuomainen; Stefan Agewall; Gerald Berenson; Alberico L Catapano; Giuseppe D Norata; Michiel L Bots; Wiek van Gilst; Folkert W Asselbergs; Frank P Brouwers; Heiko Uthoff; Dirk Sander; Holger Poppert; Michael Hecht Olsen; Jean Philippe Empana; Ulf Schminke; Damiano Baldassarre; Fabrizio Veglia; Oscar H Franco; Maryam Kavousi; Eric de Groot; Ellisiv B Mathiesen; Liliana Grigore; Joseph F Polak; Tatjana Rundek; Coen DA Stehouwer; Michael R Skilton; Apostolos I Hatzitolios; Christos Savopoulos; George Ntaios; Matthieu Plichart; Stela McLachlan; Lars Lind; Peter Willeit; Helmuth Steinmetz; Moise Desvarieux; M Arfan Ikram; Stein Harald Johnsen; Caroline Schmidt; Johann Willeit; Pierre Ducimetiere; Jackie F Price; Göran Bergström; Jussi Kauhanen; Stefan Kiechl; Matthias Sitzer; Horst Bickel; Ralph L Sacco; Albert Hofman; Henry Völzke; Simon G Thompson
Journal:  Eur J Prev Cardiol       Date:  2019-10-16       Impact factor: 7.804

Review 5.  The Role of High-Density Lipoprotein Cholesterol in 2022.

Authors:  Cesare R Sirtori; Alberto Corsini; Massimiliano Ruscica
Journal:  Curr Atheroscler Rep       Date:  2022-03-10       Impact factor: 5.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.